1. Home
  2. VYGR vs PPIH Comparison

VYGR vs PPIH Comparison

Compare VYGR & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • PPIH
  • Stock Information
  • Founded
  • VYGR 2013
  • PPIH 1993
  • Country
  • VYGR United States
  • PPIH United States
  • Employees
  • VYGR N/A
  • PPIH N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • PPIH Pollution Control Equipment
  • Sector
  • VYGR Health Care
  • PPIH Industrials
  • Exchange
  • VYGR Nasdaq
  • PPIH Nasdaq
  • Market Cap
  • VYGR 206.9M
  • PPIH 217.1M
  • IPO Year
  • VYGR 2015
  • PPIH N/A
  • Fundamental
  • Price
  • VYGR $4.24
  • PPIH $30.51
  • Analyst Decision
  • VYGR Strong Buy
  • PPIH
  • Analyst Count
  • VYGR 7
  • PPIH 0
  • Target Price
  • VYGR $14.50
  • PPIH N/A
  • AVG Volume (30 Days)
  • VYGR 678.8K
  • PPIH 125.8K
  • Earning Date
  • VYGR 08-06-2025
  • PPIH 09-19-2025
  • Dividend Yield
  • VYGR N/A
  • PPIH N/A
  • EPS Growth
  • VYGR N/A
  • PPIH N/A
  • EPS
  • VYGR N/A
  • PPIH 1.55
  • Revenue
  • VYGR $42,580,000.00
  • PPIH $170,810,000.00
  • Revenue This Year
  • VYGR N/A
  • PPIH N/A
  • Revenue Next Year
  • VYGR $107.07
  • PPIH N/A
  • P/E Ratio
  • VYGR N/A
  • PPIH $19.65
  • Revenue Growth
  • VYGR N/A
  • PPIH 9.96
  • 52 Week Low
  • VYGR $2.65
  • PPIH $8.81
  • 52 Week High
  • VYGR $8.28
  • PPIH $32.90
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 70.98
  • PPIH 60.11
  • Support Level
  • VYGR $3.32
  • PPIH $28.26
  • Resistance Level
  • VYGR $3.49
  • PPIH $32.44
  • Average True Range (ATR)
  • VYGR 0.23
  • PPIH 2.04
  • MACD
  • VYGR 0.06
  • PPIH 0.02
  • Stochastic Oscillator
  • VYGR 94.03
  • PPIH 64.06

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About PPIH Perma-Pipe International Holdings Inc.

Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.

Share on Social Networks: